DK160936C - Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer - Google Patents

Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer

Info

Publication number
DK160936C
DK160936C DK268679A DK268679A DK160936C DK 160936 C DK160936 C DK 160936C DK 268679 A DK268679 A DK 268679A DK 268679 A DK268679 A DK 268679A DK 160936 C DK160936 C DK 160936C
Authority
DK
Denmark
Prior art keywords
analogue
preparation
optically active
phenethanolamines
active phenethanolamines
Prior art date
Application number
DK268679A
Other languages
Danish (da)
English (en)
Other versions
DK268679A (da
DK160936B (da
Inventor
Jack Mills
Klaus Kurt Schmiegel
Walter Norman Shaw
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK268679A publication Critical patent/DK268679A/da
Publication of DK160936B publication Critical patent/DK160936B/da
Application granted granted Critical
Publication of DK160936C publication Critical patent/DK160936C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/06—Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
DK268679A 1978-07-03 1979-06-26 Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer DK160936C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03
US92167078 1978-07-03

Publications (3)

Publication Number Publication Date
DK268679A DK268679A (da) 1980-01-04
DK160936B DK160936B (da) 1991-05-06
DK160936C true DK160936C (da) 1991-10-21

Family

ID=25445792

Family Applications (2)

Application Number Title Priority Date Filing Date
DK268779A DK268779A (da) 1978-07-03 1979-06-26 Fremgangsmaade til fremstilling af phenethanolaminer
DK268679A DK160936C (da) 1978-07-03 1979-06-26 Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK268779A DK268779A (da) 1978-07-03 1979-06-26 Fremgangsmaade til fremstilling af phenethanolaminer

Country Status (31)

Country Link
EP (3) EP0007204B1 (bg)
JP (2) JPS559096A (bg)
KR (1) KR880002310B1 (bg)
AR (4) AR225744A1 (bg)
AT (2) AT372937B (bg)
AU (2) AU523720B2 (bg)
BE (2) BE877393A (bg)
BG (4) BG31645A3 (bg)
CA (2) CA1145767A (bg)
CH (2) CH642618A5 (bg)
CS (4) CS208663B2 (bg)
DD (2) DD144761A5 (bg)
DE (2) DE2964604D1 (bg)
DK (2) DK268779A (bg)
EG (1) EG14238A (bg)
ES (4) ES482155A1 (bg)
FI (2) FI792082A (bg)
FR (3) FR2430410B1 (bg)
GB (3) GB2101582B (bg)
GR (2) GR72940B (bg)
HU (2) HU179172B (bg)
IE (2) IE48586B1 (bg)
IL (2) IL57671A (bg)
LU (2) LU81458A1 (bg)
NZ (2) NZ190861A (bg)
PH (2) PH15275A (bg)
PL (4) PL117997B1 (bg)
PT (2) PT69843A (bg)
RO (4) RO77728A (bg)
SU (4) SU965350A3 (bg)
ZA (2) ZA793296B (bg)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
ATE2265T1 (de) * 1979-10-25 1983-02-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
DE3070865D1 (en) * 1979-11-15 1985-08-14 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
EP0040000B1 (en) * 1980-05-08 1983-10-12 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
DE3260490D1 (en) * 1981-03-31 1984-09-06 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー ２−ヒドロキシ−２−フエニルエチルアミン類の製造方法
DE3473439D1 (en) * 1983-01-31 1988-09-22 Lilly Co Eli Improvements in or relating to phenethanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
JPS60158153A (ja) * 1984-01-12 1985-08-19 イーライ・リリー・アンド・カンパニー 変力剤
ES8800842A1 (es) * 1985-03-01 1987-12-01 Beecham Group Plc Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5191112A (en) * 1989-10-17 1993-03-02 Nissan Chemical Industries, Ltd. Process for optical resolution of (±)-2-(3-benzoyl)-phenylpropionic acid
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
EP1281702B1 (en) * 1991-08-23 2005-12-21 Nps Pharmaceuticals, Inc. Calcium receptor active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
PL183499B1 (pl) 1994-10-21 2002-06-28 Nps Pharma Inc Związki do modulowania receptorów wapniowych i kompozycje farmaceutyczne
US5981599A (en) 1996-05-01 1999-11-09 Nps Pharmaceuticals, Inc. Inorganic ion receptor active compounds
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (bg) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility

Also Published As

Publication number Publication date
EP0007204B1 (en) 1982-11-24
GB2028802A (en) 1980-03-12
GB2028799A (en) 1980-03-12
IL57672A (en) 1983-03-31
DD144762A5 (de) 1980-11-05
FI792081A (fi) 1980-01-04
BE877393A (fr) 1980-01-02
HU179171B (en) 1982-08-28
DK268679A (da) 1980-01-04
AR231434A1 (es) 1984-11-30
IE791227L (en) 1980-01-03
AT372937B (de) 1983-11-25
NZ190863A (en) 1982-05-25
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
JPS6254095B2 (bg) 1987-11-13
RO83052B (ro) 1984-02-28
IL57671A (en) 1982-11-30
EP0006766B1 (en) 1983-01-26
BE877394A (fr) 1980-01-02
PL117996B1 (en) 1981-09-30
SU1007554A3 (ru) 1983-03-23
GR74524B (bg) 1984-06-29
LU81458A1 (fr) 1979-10-30
HU179172B (en) 1982-08-28
AR229080A1 (es) 1983-06-15
ES482156A1 (es) 1980-08-16
RO83051B (ro) 1984-02-28
ES8104189A1 (es) 1981-04-16
SU957761A3 (ru) 1982-09-07
FR2430411A1 (fr) 1980-02-01
RO77728A (ro) 1981-11-24
JPS559097A (en) 1980-01-22
SU849997A3 (ru) 1981-07-23
AT367025B (de) 1982-05-25
IE48769B1 (en) 1985-05-15
GB2101582B (en) 1983-06-08
PL216811A1 (bg) 1980-08-25
BG31645A3 (bg) 1982-02-15
LU81457A1 (fr) 1979-10-30
FR2450806B1 (fr) 1985-07-12
AR227165A1 (es) 1982-09-30
RO83051A (ro) 1984-02-21
ATA463679A (de) 1981-10-15
ES8104190A1 (es) 1981-04-16
GB2101582A (en) 1983-01-19
DE2964091D1 (en) 1982-12-30
AU523721B2 (en) 1982-08-12
EG14238A (en) 1983-12-31
AU4848979A (en) 1980-01-10
ES490214A0 (es) 1981-04-16
PT69839A (en) 1979-07-01
BG31646A3 (bg) 1982-02-15
DD144761A5 (de) 1980-11-05
PL216814A1 (bg) 1980-03-24
PH14522A (en) 1981-08-26
IL57671A0 (en) 1979-10-31
FR2430410A1 (fr) 1980-02-01
FR2430411B1 (bg) 1983-08-19
FR2450806A1 (fr) 1980-10-03
CS209815B2 (en) 1981-12-31
DE2964604D1 (en) 1983-03-03
PT69843A (en) 1979-07-01
ATA463579A (de) 1983-04-15
CS208664B2 (en) 1981-09-15
KR880002310B1 (ko) 1988-10-22
BG31375A3 (bg) 1981-12-15
RO77732A (ro) 1981-11-24
KR830001187A (ko) 1983-04-29
FI792082A (fi) 1980-01-04
CH643529A5 (fr) 1984-06-15
GB2028799B (en) 1982-09-08
GR72940B (bg) 1984-01-16
SU965350A3 (ru) 1982-10-07
PL117997B1 (en) 1981-09-30
DK268779A (da) 1980-01-04
CH642618A5 (fr) 1984-04-30
CA1145767A (en) 1983-05-03
BG31647A3 (bg) 1982-02-15
CS208662B2 (en) 1981-09-15
EP0006766A1 (en) 1980-01-09
ES490215A0 (es) 1981-04-16
GB2028802B (en) 1983-03-30
CS208663B2 (en) 1981-09-15
AR225744A1 (es) 1982-04-30
CA1142954A (en) 1983-03-15
EP0048037A1 (en) 1982-03-24
PL121297B1 (en) 1982-04-30
IL57672A0 (en) 1979-10-31
ZA793296B (en) 1981-02-25
DK160936B (da) 1991-05-06
JPS559096A (en) 1980-01-22
AU4848779A (en) 1980-01-10
IE48586B1 (en) 1985-03-20
RO83052A (ro) 1984-02-21
FR2430410B1 (fr) 1986-03-21
AU523720B2 (en) 1982-08-12
NZ190861A (en) 1981-12-15
ES482155A1 (es) 1980-08-16
PH15275A (en) 1982-11-02
EP0007204A1 (en) 1980-01-23
IE791228L (en) 1980-01-03

Similar Documents

Publication Publication Date Title
DK160936C (da) Analogifremgangsmaade til fremstilling af optisk aktive phenethanolaminer
DK150068C (da) Analogifremgangsmaade til fremstilling af aminothiazoler
DK325079A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK365079A (da) Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK156001C (da) Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner
DK269079A (da) Fremgangsmaade til fremstilling af phenethanolaminer
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK307279A (da) Fremgangsmaade til fremstilling af phenolethere
DK158460C (da) Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK433779A (da) Fremgangsmaade til fremstilling af phenylquinolizidiner
DK215079A (da) Fremgangsmaade til fremstilling af phenylaminothiothiopheneddikesyrer
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK160485C (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK233379A (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK16779A (da) Fremgangsmaade til fremstilling af betaendoprphinanaloge
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK145422C (da) Fremgangsmaade til fremstilling af ursodesoxycholsyre
DK159771C (da) Fremgangsmaade til fremstillingen af cyklopropancarboxylsyreestere
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider
DK239279A (da) Fremgangsmaade til fremstilling af 2-oximinophenylacetonitril
DK333579A (da) Analogifremgangsmaade til fremstilling af thiophencarboxamidoalkylmercaptaner
DK147183C (da) Fremgangsmaade til fremstilling af l-alfa-glycerophosphatoxidase

Legal Events

Date Code Title Description
PBP Patent lapsed